Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
about
Microbial ureases: significance, regulation, and molecular characterizationProspects for preventionGenetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infectionStandardizing the reporting of percutaneous nephrolithotomy complications.Using verapamil as protective factor in renal ischemia reperfusion injury during anatrophic nephrolithotomy.
P2860
Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi.
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@ast
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@en
type
label
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@ast
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@en
prefLabel
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@ast
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@en
P2093
P1476
Acetohydroxamic acid: clinical ...... s with staghorn renal calculi.
@en
P2093
Clinton CW
Griffith DP
P407
P577
1978-01-01T00:00:00Z